Teen Cannabis Use Hits New Low as U.S. Legalization Reaches 28 States

Survey Data Shows Four-Year Decline Across All Grade Levels

Past-30-day cannabis use among 12th graders fell to 14.7% in 2026, down from 19.3% in 2022 and marking the fourth consecutive annual decline. The University of Michigan's Monitoring the Future project, funded by the National Institute on Drug Abuse, surveyed approximately 32,000 students across 8th, 10th, and 12th grades between February and May 2026. Eighth-grade use dropped to 4.1%. That's the lowest figure since the survey began tracking cannabis separately from other substances in 1991.

The steepest decline occurred among 10th graders, where past-month use fell from 17.3% in 2022 to 9.8% in 2026. Daily use—defined as consumption on 20 or more occasions in the past 30 days—also declined across all three grade cohorts, with 12th-grade daily use dropping to 2.9% from 4.6% four years prior.

Researchers attribute part of the decline to sustained public health messaging and stricter retail compliance enforcement in legal states. Michigan, which legalized adult use in 2018, reported a 47% reduction in teen consumption between 2019 and 2025, according to state Department of Health and Human Services data cited in the survey analysis.

Legalization's Inverse Correlation With Youth Access

States with regulated adult-use markets showed steeper declines in adolescent use than prohibition states over the 2022-2026 period. Colorado, Washington, Oregon, and California—the four longest-running legal markets—recorded an average 6.2 percentage-point drop in high school senior use, compared to a 3.8-point decline in the 22 states that maintained full prohibition through 2026.

The data contradicts the "gateway normalization" hypothesis advanced by groups like Smart Approaches to Marijuana. Kevin Sabet, SAM's president, argued in a July 2024 op-ed that legalization would "flood schools with high-potency products and erase decades of prevention gains." That prediction hasn't materialized. Regulated markets appear to reduce youth access by eliminating the unregulated dealer networks that historically served minors without age verification.

Mexico's experience offers a useful parallel. After the country legalized adult use in April 2024, the Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz tracked a 12% decline in reported cannabis use among 15-to-17-year-olds over the subsequent 18 months. Researchers there noted that formalización—the shift from illicit to licensed supply chains—removed the economic incentive for dealers to target adolescents.

Vaping and Edibles Displace Combustion Among Remaining Users

Among the 14.7% of seniors who reported past-month use, vaping cartridges and edibles accounted for 68% of consumption methods, up from 51% in 2022. Traditional smoking—joints, blunts, and pipes—continued its decade-long decline, now representing just 32% of teen consumption. The shift mirrors adult market trends, where vape pens and gummies dominate sales in every major legal state.

Public health advocates view the format shift as a mixed outcome. Vaping eliminates combustion-related harms but raises concerns about discreet use and potency. The average THC concentration in youth-reported vape cartridges was 74% in 2026, compared to 18% in flower products. Total grams consumed per month declined even as potency rose, suggesting that higher-THC products don't necessarily increase aggregate exposure.

Colombia's regulatory model offers one policy response. The country's 2025 adult-use law capped vape cartridge potency at 60% THC and required child-resistant packaging with prominent health warnings. Early compliance data from Bogotá and Medellín shows retailers adhering to the limits, and adolescent vaping rates there remain below 3%.

Policy Implications for Federal Rescheduling and State Rollouts

The sustained decline in teen use strengthens the case for federal rescheduling and provides a rebuttal to delay tactics in state legislatures. The DEA's ongoing review of cannabis's Schedule I status has cited youth access concerns as a potential barrier to rescheduling, despite HHS recommending Schedule III placement in 2023. The new MTF data undermines that rationale by demonstrating that expanded legal access for adults correlates with reduced adolescent consumption.

State lawmakers in holdout jurisdictions—including Georgia, Texas, and North Carolina—have repeatedly invoked youth protection as grounds for opposing legalization bills. Georgia's HB 441, which failed in committee in March 2026, was blocked by legislators who argued that legal sales would "normalize drug use in schools." The MTF data suggests the opposite dynamic: regulated markets with strict compliance enforcement reduce teen access more effectively than prohibition.

For full background on this story, see the CannIntel topic hub on teen cannabis use trends. Observers will be watching whether the 2027 MTF survey, scheduled for release next July, shows continued declines as additional states—including Ohio, Kentucky, and Pennsylvania—launch adult-use programs in late 2026 and early 2027.